ÇELİK, İ. Et Al. 2022. SARS-CoV-2 Infection may be prevented with Cytochrome Inhibitors: Cobistat and Ritonavir. Infectious diseases and clinical microbiology (Online) , vol.4, no.3 , 185-191.

ÇELİK, İ., GÜLTEN, E., ONAY, A., ÇINAR, G., AKDEMİR KALKAN, İ., KILCIGİL, G., ... MEMİKOĞLU, K. O.(2022). SARS-CoV-2 Infection may be prevented with Cytochrome Inhibitors: Cobistat and Ritonavir. Infectious diseases and clinical microbiology (Online) , vol.4, no.3, 185-191.

ÇELİK, İSMAİL Et Al. "SARS-CoV-2 Infection may be prevented with Cytochrome Inhibitors: Cobistat and Ritonavir," Infectious diseases and clinical microbiology (Online) , vol.4, no.3, 185-191, 2022

ÇELİK, İSMAİL Et Al. "SARS-CoV-2 Infection may be prevented with Cytochrome Inhibitors: Cobistat and Ritonavir." Infectious diseases and clinical microbiology (Online) , vol.4, no.3, pp.185-191, 2022

ÇELİK, İ. Et Al. (2022) . "SARS-CoV-2 Infection may be prevented with Cytochrome Inhibitors: Cobistat and Ritonavir." Infectious diseases and clinical microbiology (Online) , vol.4, no.3, pp.185-191.

@article{article, author={İSMAİL ÇELİK Et Al. }, title={SARS-CoV-2 Infection may be prevented with Cytochrome Inhibitors: Cobistat and Ritonavir}, journal={Infectious diseases and clinical microbiology (Online)}, year=2022, pages={185-191} }